The "Europe Chronic Obstructive Pulmonary Disease Epidemiology and Patient Flow Analysis 2018" report has been added to ResearchAndMarkets.com's offering.
This research provides insights into Chronic Obstructive Pulmonary Disease epidemiology, Chronic Obstructive Pulmonary Disease diagnosed patients, and Chronic Obstructive Pulmonary Disease treatment rate for EU5 countries. The research measures key indicators including prevalence of Chronic Obstructive Pulmonary Disease derived from epidemiological analysis, patients diagnosed with Chronic Obstructive Pulmonary Disease, and patients treated with a drug therapy.
The research study helps executives estimate Chronic Obstructive Pulmonary Disease market potential, assess unmet need, develop drug forecasting models, and build population-based health management frameworks. The information presented in this study is used to evaluate market opportunities, effectively identify target patient population, and align marketing decisions.
The research provides estimates and forecasts of Chronic Obstructive Pulmonary Disease prevalence, Chronic Obstructive Pulmonary Disease diagnosis rate, and Chronic Obstructive Pulmonary Disease treatment rate for the period 2017-2026. The information is presented by EU5 countries including Germany, France, Spain, Italy, and UK.
Key Topics Covered
1. Chronic Obstructive Pulmonary Disease: Disease Definition
2. Chronic Obstructive Pulmonary Disease Patient Flow in Europe
3. Chronic Obstructive Pulmonary Disease Patient Flow in Germany
4. Chronic Obstructive Pulmonary Disease Patient Flow in France
5. Chronic Obstructive Pulmonary Disease Patient Flow in Spain
6. Chronic Obstructive Pulmonary Disease Patient Flow in Italy
7. Chronic Obstructive Pulmonary Disease Patient Flow in UK
8. Research Methodology
For more information about this report visit https://www.researchandmarkets.com/research/5sz8n3/european_chronic?w=4
View source version on businesswire.com: https://www.businesswire.com/news/home/20180702006004/en/
Contacts:
ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Respiratory Drugs
